Event Type: Conference call with Analysts/Investors on Financial Results for Q1 FY27 (quarter ended 30th June, 2026)
Date of Disclosure: 04th August, 2026
Purpose: Discussion of financial results for the quarter ended 30th June, 2026
Timing Relative to Earnings: Post-results investor interaction (following results announcement)
Management Participants: Not specified in this disclosure
Availability: Transcript has been placed on the Company's website at https://torrentpharma.com/pdf/investors/Q1-FY26-27_Earnings-Call-Transcript.pdf
Regulatory Compliance: Filed pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Additional Notes Section
Continuation Reference: This filing is in continuation of the company's letter dated 17th July, 2026
Financial Data Disclosure: No financial figures or performance data are disclosed in this announcement - only the availability of the transcript is notified
Compliance Language: Standard regulatory disclosure language used for exchange compliance
